A controlled clinical trial to evaluate the efficacy of Rasona Haritaki Vati in the management of Dyslipidemia with special reference to Medoroga
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 入组人数
- 80
- 试验地点
- 1
- 主要终点
- There will be significant improvement in lipid profile of patient.
研究概览
简要总结
• Selection .Of .Patients:- .Following .a .comprehensive .history .taking, .clinical, .and laboratory .evaluations, .a .total .no. .of 80 .patients .with .clinical .symptoms .of .Dyslipidemia (Medoroga) .will .be .chosen .from .the .OPD .and .IPD .of .Kayachikitsa, .S. .S. .Hospital, .IMS, .B.H.U., .Varanasi .based .on .inclusion .and .exclusion .criteria.
• Duration .of .treatment: **.**3 .months .with .follow .up .at .30 .days .of . .interval.
• DOSE: Rasona Haritaki Vati - 500 mg BD
Atorvastatin- 40 mg OD
Grouping: Patient .will .be .selected .according .to .the .inclusion .or .exclusion .criteria .and .those .who .are .fulfilling .the .criteria .will .be .randomly .divided .into .two .groups (40 in each group). .
• Group .A: .- **.**Rasona .Haritaki Vati
• Group .B: .- .Atorvastatin
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 21.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •patients of age group between 21 to 60 years.
- •patient willing to enrolled in study.
排除标准
- •age group less than 21 and more than 60 years of age.
- •patient not willing for trial.
结局指标
主要结局
There will be significant improvement in lipid profile of patient.
时间窗: 3 month
次要结局
- Secondary outcome- Reduction in symptoms of Dyslipidemia and improve quality of life.
研究者
NIHARIKA GAUTAM
Faculty of Ayurveda IMS BHU